Ajanta Pharma net profit rises 64 percent to Rs 177 crore in Q3
New Delhi: Drug firm Ajanta Pharma on Tuesday reported a 64 percent rise in its consolidated net profit to Rs 177 crore for the quarter ended December mainly on account of robust sales.
The company had posted a net profit of Rs 108 crore for the corresponding period of the previous fiscal, Ajanta Pharma said in a BSE filing.
Read also: Sun Pharma net profit doubles to Rs 1,852 crore in Q3
Consolidated revenue from operations of the company stood at Rs 749 crore for the quarter under consideration. It was Rs 651 crore for the same period a year ago, it added.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.